nodes	percent_of_prediction	percent_of_DWPC	metapath
Nedocromil—PTGDR—adrenal gland—adrenal gland cancer	0.0113	0.272	CbGeAlD
Nedocromil—HSP90AA1—adrenal cortex—adrenal gland cancer	0.00601	0.145	CbGeAlD
Nedocromil—CYSLTR1—adrenal gland—adrenal gland cancer	0.005	0.121	CbGeAlD
Nedocromil—HSP90AA1—gonad—adrenal gland cancer	0.00498	0.12	CbGeAlD
Nedocromil—HSP90AA1—cardiac atrium—adrenal gland cancer	0.00497	0.12	CbGeAlD
Nedocromil—HSP90AA1—pituitary gland—adrenal gland cancer	0.00486	0.117	CbGeAlD
Nedocromil—HSP90AA1—adrenal gland—adrenal gland cancer	0.00434	0.105	CbGeAlD
Nedocromil—HSP90AA1—Signaling by VEGF—PRKACA—adrenal gland cancer	0.00424	0.00442	CbGpPWpGaD
Nedocromil—HSP90AA1—EPH-Ephrin signaling—CDC42—adrenal gland cancer	0.00422	0.00441	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—SPRY2—adrenal gland cancer	0.00422	0.0044	CbGpPWpGaD
Nedocromil—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00414	0.00432	CbGpPWpGaD
Nedocromil—HSP90AA1—Corticotropin-releasing hormone—GNAS—adrenal gland cancer	0.00411	0.00428	CbGpPWpGaD
Nedocromil—FPR1—Peptide ligand-binding receptors—POMC—adrenal gland cancer	0.0041	0.00428	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR ligand binding—TSHR—adrenal gland cancer	0.00406	0.00423	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—GNRHR—adrenal gland cancer	0.0039	0.00407	CbGpPWpGaD
Nedocromil—HSP90AA1—Validated targets of C-MYC transcriptional activation—TERT—adrenal gland cancer	0.00389	0.00406	CbGpPWpGaD
Nedocromil—HSP90AA1—Aryl Hydrocarbon Receptor—PTGS2—adrenal gland cancer	0.00384	0.00401	CbGpPWpGaD
Nedocromil—HSP90AA1—VEGFA-VEGFR2 Pathway—CDC42—adrenal gland cancer	0.00381	0.00397	CbGpPWpGaD
Nedocromil—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00369	0.00385	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by VEGF—CDC42—adrenal gland cancer	0.00359	0.00375	CbGpPWpGaD
Nedocromil—HSP90AA1—Integrin-linked kinase signaling—CTNNB1—adrenal gland cancer	0.0035	0.00365	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling events mediated by VEGFR1 and VEGFR2—BRAF—adrenal gland cancer	0.00348	0.00363	CbGpPWpGaD
Nedocromil—FPR1—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00346	0.00361	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00339	0.00354	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00328	0.00342	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by ERBB2—PRKACA—adrenal gland cancer	0.00321	0.00334	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00316	0.00329	CbGpPWpGaD
Nedocromil—FPR1—GPCR ligand binding—GNAS—adrenal gland cancer	0.00311	0.00325	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00308	0.00322	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—GNRHR—adrenal gland cancer	0.00304	0.00317	CbGpPWpGaD
Nedocromil—HSP90AA1—Glucocorticoid receptor regulatory network—POMC—adrenal gland cancer	0.00303	0.00316	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00303	0.00316	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—NR5A1—adrenal gland cancer	0.00301	0.00314	CbGpPWpGaD
Nedocromil—PTGDR—GPCR ligand binding—GNAS—adrenal gland cancer	0.00301	0.00314	CbGpPWpGaD
Nedocromil—HSP90AA1—TNF alpha Signaling Pathway—BAD—adrenal gland cancer	0.003	0.00313	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00298	0.00311	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00298	0.00311	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—PRKACA—adrenal gland cancer	0.00295	0.00308	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—GNRHR—adrenal gland cancer	0.00294	0.00306	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00292	0.00305	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00283	0.00295	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR ligand binding—TSHR—adrenal gland cancer	0.00281	0.00293	CbGpPWpGaD
Nedocromil—HSP90AA1—Corticotropin-releasing hormone—POMC—adrenal gland cancer	0.00276	0.00288	CbGpPWpGaD
Nedocromil—FPR1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00275	0.00287	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—TSHR—adrenal gland cancer	0.00275	0.00287	CbGpPWpGaD
Nedocromil—HSP90AA1—Corticotropin-releasing hormone—BRAF—adrenal gland cancer	0.00273	0.00285	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00273	0.00285	CbGpPWpGaD
Nedocromil—HSP90AA1—Aryl Hydrocarbon Receptor Pathway—EGFR—adrenal gland cancer	0.00272	0.00284	CbGpPWpGaD
Nedocromil—HSP90AA1—Aryl Hydrocarbon Receptor—EGFR—adrenal gland cancer	0.00272	0.00284	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—GNRHR—adrenal gland cancer	0.0027	0.00282	CbGpPWpGaD
Nedocromil—PTGDR—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00266	0.00277	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00266	0.00277	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—TSHR—adrenal gland cancer	0.00265	0.00277	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00257	0.00268	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00257	0.00268	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling events mediated by VEGFR1 and VEGFR2—CTNNB1—adrenal gland cancer	0.00251	0.00262	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—CDC42—adrenal gland cancer	0.0025	0.00261	CbGpPWpGaD
Nedocromil—HSP90AA1—LKB1 signaling events—TP53—adrenal gland cancer	0.00241	0.00252	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR ligand binding—GNAS—adrenal gland cancer	0.00236	0.00246	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00234	0.00244	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—GNRHR—adrenal gland cancer	0.0023	0.0024	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00229	0.00239	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00214	0.00223	CbGpPWpGaD
Nedocromil—FPR1—GPCR ligand binding—POMC—adrenal gland cancer	0.0021	0.00219	CbGpPWpGaD
Nedocromil—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00209	0.00218	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—TSHR—adrenal gland cancer	0.00208	0.00217	CbGpPWpGaD
Nedocromil—PTGDR—GPCR ligand binding—POMC—adrenal gland cancer	0.00202	0.00211	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00201	0.0021	CbGpPWpGaD
Nedocromil—HSP90AA1—Regulation of Telomerase—EGFR—adrenal gland cancer	0.00199	0.00208	CbGpPWpGaD
Nedocromil—HSP90AA1—Corticotropin-releasing hormone—CTNNB1—adrenal gland cancer	0.00197	0.00206	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00197	0.00206	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—PRKACA—adrenal gland cancer	0.0019	0.00199	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by ERBB2—BAD—adrenal gland cancer	0.0019	0.00198	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00184	0.00192	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—GNRH1—adrenal gland cancer	0.00182	0.0019	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—MED12—adrenal gland cancer	0.00181	0.00189	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00178	0.00186	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00178	0.00186	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00176	0.00184	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—GNRH1—adrenal gland cancer	0.00176	0.00183	CbGpPWpGaD
Nedocromil—HSP90AA1—VEGFA-VEGFR2 Pathway—CTNNB1—adrenal gland cancer	0.00175	0.00182	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—BAD—adrenal gland cancer	0.00175	0.00182	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—GNAS—adrenal gland cancer	0.0017	0.00177	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—CDC42—adrenal gland cancer	0.00167	0.00174	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—SPRY2—adrenal gland cancer	0.00167	0.00174	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by VEGF—CTNNB1—adrenal gland cancer	0.00165	0.00172	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—SH3KBP1—adrenal gland cancer	0.00165	0.00172	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR ligand binding—GNAS—adrenal gland cancer	0.00164	0.00171	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—TSHR—adrenal gland cancer	0.00162	0.00169	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00162	0.00169	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—CDC42—adrenal gland cancer	0.00162	0.00169	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—SPRY2—adrenal gland cancer	0.00161	0.00168	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—GNAS—adrenal gland cancer	0.0016	0.00167	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—GNRHR—adrenal gland cancer	0.0016	0.00167	CbGpPWpGaD
Nedocromil—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00159	0.00166	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00159	0.00166	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR ligand binding—POMC—adrenal gland cancer	0.00159	0.00166	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—CDC42—adrenal gland cancer	0.00157	0.00164	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—TSHR—adrenal gland cancer	0.00157	0.00164	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—TOP2A—adrenal gland cancer	0.00155	0.00162	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—GNAS—adrenal gland cancer	0.00154	0.00161	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—MEN1—adrenal gland cancer	0.00153	0.00159	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—SH3KBP1—adrenal gland cancer	0.00152	0.00159	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—SDHB—adrenal gland cancer	0.0015	0.00156	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00149	0.00156	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00148	0.00155	CbGpPWpGaD
Nedocromil—HSP90AA1—Validated targets of C-MYC transcriptional activation—TP53—adrenal gland cancer	0.00148	0.00155	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—MEN1—adrenal gland cancer	0.00147	0.00154	CbGpPWpGaD
Nedocromil—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00145	0.00151	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—TSHR—adrenal gland cancer	0.00144	0.00151	CbGpPWpGaD
Nedocromil—HSP90AA1—Glucocorticoid receptor regulatory network—TP53—adrenal gland cancer	0.00144	0.0015	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—ZNRF3—adrenal gland cancer	0.00143	0.00149	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—CDC42—adrenal gland cancer	0.0014	0.00146	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.0014	0.00146	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—TOP2A—adrenal gland cancer	0.00139	0.00145	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—GNRH1—adrenal gland cancer	0.00138	0.00144	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—PRKACA—adrenal gland cancer	0.00137	0.00143	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00133	0.00139	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—CDC42—adrenal gland cancer	0.00127	0.00132	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—SPRY2—adrenal gland cancer	0.00126	0.00132	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—TSHR—adrenal gland cancer	0.00123	0.00128	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—PRKACA—adrenal gland cancer	0.00122	0.00128	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—GNAS—adrenal gland cancer	0.00121	0.00126	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—POMC—adrenal gland cancer	0.00118	0.00124	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—PRKACA—adrenal gland cancer	0.00117	0.00122	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—PRKACA—adrenal gland cancer	0.00116	0.00122	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—MEN1—adrenal gland cancer	0.00116	0.00121	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—RB1—adrenal gland cancer	0.00115	0.0012	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—GNRHR—adrenal gland cancer	0.00115	0.0012	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—POMC—adrenal gland cancer	0.00114	0.00119	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—PRKACA—adrenal gland cancer	0.00112	0.00117	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—CDC42—adrenal gland cancer	0.00112	0.00117	CbGpPWpGaD
Nedocromil—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.0011	0.00115	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR ligand binding—POMC—adrenal gland cancer	0.0011	0.00115	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—POMC—adrenal gland cancer	0.00108	0.00112	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00107	0.00111	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—POMC—adrenal gland cancer	0.00104	0.00108	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00104	0.00108	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—CDKN2A—adrenal gland cancer	0.00101	0.00106	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.001	0.00105	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by ERBB2—EGFR—adrenal gland cancer	0.000989	0.00103	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—CDC42—adrenal gland cancer	0.000989	0.00103	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CDC42—adrenal gland cancer	0.000988	0.00103	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000967	0.00101	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—SDHD—adrenal gland cancer	0.000966	0.00101	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—RRM1—adrenal gland cancer	0.000966	0.00101	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—GNRH1—adrenal gland cancer	0.000956	0.000998	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CDC42—adrenal gland cancer	0.000954	0.000995	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—IGF2—adrenal gland cancer	0.000952	0.000993	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—GNAS—adrenal gland cancer	0.000944	0.000985	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000924	0.000964	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000921	0.000961	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—IGF2—adrenal gland cancer	0.00092	0.000959	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—GNAS—adrenal gland cancer	0.000912	0.000951	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—EGFR—adrenal gland cancer	0.00091	0.000949	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—POMC—adrenal gland cancer	0.000898	0.000937	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—SPRY2—adrenal gland cancer	0.000897	0.000935	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—IGF1R—adrenal gland cancer	0.000889	0.000928	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—PRKACA—adrenal gland cancer	0.000883	0.000921	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—CDC42—adrenal gland cancer	0.000879	0.000917	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—SPRY2—adrenal gland cancer	0.000875	0.000913	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—TSHR—adrenal gland cancer	0.000853	0.000889	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—GNAS—adrenal gland cancer	0.000839	0.000876	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—TERT—adrenal gland cancer	0.000832	0.000868	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—MEN1—adrenal gland cancer	0.000822	0.000857	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—POMC—adrenal gland cancer	0.000815	0.000851	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—MEN1—adrenal gland cancer	0.000802	0.000836	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—TERT—adrenal gland cancer	0.000793	0.000827	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—TERT—adrenal gland cancer	0.000765	0.000799	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CDC42—adrenal gland cancer	0.000749	0.000781	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—RB1—adrenal gland cancer	0.000724	0.000755	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—IGF2—adrenal gland cancer	0.000722	0.000753	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—MED12—adrenal gland cancer	0.00072	0.000751	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—GNAS—adrenal gland cancer	0.000715	0.000746	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—IGF1R—adrenal gland cancer	0.000698	0.000728	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—BAD—adrenal gland cancer	0.00069	0.00072	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—BAD—adrenal gland cancer	0.000689	0.000719	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—GNRH1—adrenal gland cancer	0.000687	0.000716	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—PRKACA—adrenal gland cancer	0.000679	0.000709	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—BAD—adrenal gland cancer	0.000666	0.000695	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—RB1—adrenal gland cancer	0.000647	0.000675	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—CDKN2A—adrenal gland cancer	0.000636	0.000664	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—POMC—adrenal gland cancer	0.000636	0.000663	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—SPRY2—adrenal gland cancer	0.000628	0.000655	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—BRAF—adrenal gland cancer	0.000628	0.000655	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—PRKACA—adrenal gland cancer	0.000627	0.000654	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—POMC—adrenal gland cancer	0.000622	0.000649	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—POMC—adrenal gland cancer	0.000614	0.00064	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—TSHR—adrenal gland cancer	0.000612	0.000638	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PRKACA—adrenal gland cancer	0.000612	0.000638	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—EGFR—adrenal gland cancer	0.000608	0.000635	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—BRAF—adrenal gland cancer	0.000606	0.000632	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—TERT—adrenal gland cancer	0.000601	0.000627	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—EGFR—adrenal gland cancer	0.000588	0.000613	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CDC42—adrenal gland cancer	0.000576	0.000601	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—MEN1—adrenal gland cancer	0.000575	0.0006	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—EGFR—adrenal gland cancer	0.000571	0.000596	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—CDKN2A—adrenal gland cancer	0.000569	0.000594	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—POMC—adrenal gland cancer	0.000565	0.00059	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—TP53—adrenal gland cancer	0.000565	0.000589	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—CDC42—adrenal gland cancer	0.000532	0.000555	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PRKACA—adrenal gland cancer	0.000525	0.000548	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—BAD—adrenal gland cancer	0.000523	0.000545	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CDC42—adrenal gland cancer	0.000519	0.000541	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—CTNNB1—adrenal gland cancer	0.000514	0.000537	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—IGF2—adrenal gland cancer	0.0005	0.000522	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—GNAS—adrenal gland cancer	0.000496	0.000517	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000484	0.000505	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—POMC—adrenal gland cancer	0.000482	0.000503	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—BRAF—adrenal gland cancer	0.000476	0.000496	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—EGFR—adrenal gland cancer	0.000461	0.000481	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—CTNNB1—adrenal gland cancer	0.000454	0.000474	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000454	0.000473	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PRKACA—adrenal gland cancer	0.000439	0.000458	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000438	0.000457	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—TERT—adrenal gland cancer	0.000427	0.000445	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—GNAS—adrenal gland cancer	0.000426	0.000444	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—ABCB1—adrenal gland cancer	0.000418	0.000436	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—TERT—adrenal gland cancer	0.000416	0.000434	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—EGFR—adrenal gland cancer	0.000407	0.000425	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—BAD—adrenal gland cancer	0.000402	0.000419	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CDC42—adrenal gland cancer	0.000373	0.000389	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—BAD—adrenal gland cancer	0.000371	0.000387	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—BAD—adrenal gland cancer	0.000362	0.000378	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—EGFR—adrenal gland cancer	0.00036	0.000375	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—EGFR—adrenal gland cancer	0.000359	0.000375	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—IGF2—adrenal gland cancer	0.000359	0.000375	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—GNAS—adrenal gland cancer	0.000356	0.000371	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000347	0.000362	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—EGFR—adrenal gland cancer	0.000347	0.000362	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000344	0.000359	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—BRAF—adrenal gland cancer	0.000338	0.000353	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—POMC—adrenal gland cancer	0.000334	0.000348	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—BRAF—adrenal gland cancer	0.00033	0.000344	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—EGFR—adrenal gland cancer	0.00032	0.000333	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—TP53—adrenal gland cancer	0.000317	0.00033	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—TP53—adrenal gland cancer	0.000302	0.000315	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—TERT—adrenal gland cancer	0.000299	0.000312	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—TP53—adrenal gland cancer	0.000291	0.000304	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—POMC—adrenal gland cancer	0.000287	0.000299	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—PTGS2—adrenal gland cancer	0.000273	0.000285	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—EGFR—adrenal gland cancer	0.000272	0.000284	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CTNNB1—adrenal gland cancer	0.000265	0.000276	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—BAD—adrenal gland cancer	0.00026	0.000271	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—CTNNB1—adrenal gland cancer	0.000244	0.000255	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—POMC—adrenal gland cancer	0.00024	0.00025	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000238	0.000249	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—BRAF—adrenal gland cancer	0.000237	0.000247	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—TP53—adrenal gland cancer	0.000229	0.000239	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PTGS2—adrenal gland cancer	0.000229	0.000239	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—EGFR—adrenal gland cancer	0.00021	0.000219	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—EGFR—adrenal gland cancer	0.000194	0.000202	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—EGFR—adrenal gland cancer	0.000189	0.000197	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000171	0.000178	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—TP53—adrenal gland cancer	0.000159	0.000165	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—EGFR—adrenal gland cancer	0.000136	0.000141	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—TP53—adrenal gland cancer	0.000114	0.000119	CbGpPWpGaD
